1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Fortún J, Gioia F, Muñoz P, Graus J, Gómez-García de la Pedrosa E, Martín-Dávila P, Saiz A, Vena A, Moreno S.

    T2 magnetic resonance for the diagnosis of deep-seated invasive candidiasis in a liver recipient without candidemia.

    REVISTA IBEROAMERICANA DE MICOLOGIA . 35(3): 159-161.

    [doi:10.1016/j.riam.2018.03.002]

  • Deusch S, Serrano-Villar S, Rojo D, Martínez-Martínez M, Bargiela R, Vázquez-Castellanos JF, Sainz T, Barbas C, Moya A, Moreno S, Gosalbes MJ, Estrada V, Seifert J, Ferrer M.

    Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota.

    AIDS . 32(10): 1229-1237. Nº de citas: 26

    [doi:10.1097/QAD.0000000000001831]

  • Zegri-Reiriz I, de Alarcón A, Muñoz P, Martínez Sellés M, González-Ramallo V, Miro JM, Falces C, Gonzalez Rico C, Kortajarena Urkola X, Lepe JA, Rodriguez Alvarez R, Reguera Iglesias JM, Navas E, Dominguez F, Garcia-Pavia P.

    Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse.

    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY . 71(24): 2731-2740. Nº de citas: 72

    [doi:10.1016/j.jacc.2018.03.534]

  • Ndumbi P, Del Romero J, Pulido F, Velasco Arribas M, Dronda F, Blanco Ramos JR, García de Olalla P, Ocaña I, Belda-Ibañez J, Del Amo J, Álvarez-Del Arco D, aMASE Research Group.

    Barriers to health care services for migrants living with HIV in Spain.

    EUROPEAN JOURNAL OF PUBLIC HEALTH . 28(3): 451-457. Nº de citas: 30

    [doi:10.1093/eurpub/ckx225]

  • Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S, and the GESIDA 3603b Study Group.

    Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.

    AIDS . 32(9): 1095-1105. Nº de citas: 35

    [doi:10.1097/QAD.0000000000001787]

  • Domínguez-Alegría AR, Pintado V, Barbolla I.

    Treatment and prevention of invasive pneumococcal disease.

    REVISTA CLINICA ESPANOLA . 218(5): 244-252. Nº de citas: 9

    [doi:10.1016/j.rce.2018.01.004]

  • Cascajero A, Rastrojo A, Díez-Fuertes F, Hernández-Novoa B, Aguado B, Moreno S, Alcami J, Pérez-Olmeda M.

    Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.

    JOURNAL OF VIROLOGY . 92(11): . Nº de citas: 4

    [doi:10.1128/JVI.00390-18]

  • Reinwald M, Silva JT, Mueller NJ, Fortún J, Garzoni C, de Fijter JW, Fernández-Ruiz M, Grossi P, Aguado JM.

    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors).

    CLINICAL MICROBIOLOGY AND INFECTION . 24 Suppl 2: 53-70. Nº de citas: 141

    [doi:10.1016/j.cmi.2018.02.009]

  • Aguado R, Páez-Vega A, Agüera ML, Montejo M, Guirado L, Fortún J, Suárez-Benjumea A, Len O, Fariñas MC, de Gracia C, Hernández D, Cobos-Ceballos MJ, Torre-Cisneros J, Cantisán S.

    Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients.

    HUMAN IMMUNOLOGY . 79(6): 499-505. Nº de citas: 4

    [doi:10.1016/j.humimm.2018.03.009]

  • Casado JL, Monsalvo M, Rojo AM, Fontecha M, Rodriguez-Sagrado MA.

    Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection.

    Expert Review of Clinical Pharmacology . 11(6): 561-570.

    [doi:10.1080/17512433.2018.1478726]

  • Valencia J, Ryan P, Alvaro-Meca A, Troya J, Gutierrez J, Cuevas G, Moreno S.

    High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis.

    AIDS . 32(9): 1157-1163. Nº de citas: 3

    [doi:10.1097/QAD.0000000000001806]

  • Navarro M, Navaza B, Guionnet A, López-Vélez R.

    Overcoming Barriers to HIV Prevention and Healthcare Among Sub-Saharan African Migrants in Spain.

    JMIR Public Health and Surveillance . 4(2): 10478-10478.

    [doi:10.2196/10478]

  • Llop M, Sifuentes WA, Bañón S, Macia-Villa C, Perez-Elías MJ, Rosillo M, Moreno S, Vázquez M, Casado JL.

    Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age.

    Archives of Osteoporosis . 13(1): 56-56. Nº de citas: 10

    [doi:10.1007/s11657-018-0464-2]

  • Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

    Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

    CLINICAL MICROBIOLOGY AND INFECTION . 24 Suppl 1: .

    [doi:10.1016/j.cmi.2018.01.002]

  • Madrid-Elena N, García-Bermejo ML, Serrano-Villar S, Díaz-de Santiago A, Sastre B, Gutiérrez C, Dronda F, Coronel Díaz M, Domínguez E, López-Huertas MR, Hernández-Novoa B, Moreno S.

    Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-?B Activation in Resting CD4 + T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.

    JOURNAL OF VIROLOGY . 92(9): . Nº de citas: 44

    [doi:10.1128/JVI.01931-17]

  • Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, Gatell JM.

    Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 36(5): 268-276. Nº de citas: 6

    [doi:10.1016/j.eimc.2017.04.002]

  • Miró G, López-Vélez R.

    Clinical management of canine leishmaniosis versus human leishmaniasis due to Leishmania infantum: Putting One Health principles into practice.

    VETERINARY PARASITOLOGY . 254: 151-159. Nº de citas: 42

    [doi:10.1016/j.vetpar.2018.03.002]

  • Cervero M, Torres R, Agud JL, Alcázar V, Jusdado JJ, García-Lacalle C, Moreno S.

    Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients.

    Plos One . 13(4): . Nº de citas: 16

    [doi:10.1371/journal.pone.0196201]